Bill Sibold, Madrigal Pharma CEO, joins ‘Fast Money’ to talk how Rezdiffra stacks up to competitors in the MASH treatment space, sales growth for the drug over the last year, and more.
04:30
Thu, Oct 16 20255:58 PM EDT
Trending
- Final Trades: Baidu, Coinbase, Delta, SLB
- Whipsaw in flows catches S&P 500
- IBM reports software revenue in line with estimates
- IBM, Tesla, Moderna and more
- Trump admin sanctions Russian oil companies, presses for Ukraine ceasefire
- 'Fast Money' traders talk recent spike in market volatility
- Crypto execs meet with senators to push forward market structure legislation: CNBC Crypto World
- Southwest Airlines (LUV) earnings Q3 2025
Madrigal Pharma CEO talks competition in the liver disease treatment space
